Gov. Tim Walz (D-MN) is living a “sad existence” for cheering the demise of Elon Musk ‘s car company, the White House said Wednesday.

The company said that more than 800 people have been treated with Elevidys, with only one experiencing liver failure.

New data show that AMC's failure-to-deliver rates have peaked over the past two months. With this key indicator sitting at an all-time high, here’s what investors should know. Rocketing trade ...

What's at stake with SVB's failure. How SVB failed. Implications and questions. Bottom line for investors. Investors in SIVB stock will suffer a catastrophic and total loss. But beyond individual ...

Delivered daily. Enter your email in the box and click Sign Me Up. With over a decade of experience writing about the stock market, Karee Venema is the senior investing editor at Kiplinger.com.

Sarepta Therapeutics (SRPT) stock drops 25% as the company reports a patient death linked to Elevidys, its gene therapy developed with Roche (RHHBY). Read more here.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) stock is sliding. The company shared an update on Elevidys (delandistrogene moxeparvovec-rokl), the only approved gene therapy in patients with Duchenne ...

Sarepta Therapeutics said a patient taking its treatment for Duchenne muscular dystrophy has died from acute liver failure.

Sarasin & Partners, representing over 600 investors, has sold its Equinor stock, citing the oil major's failure to align its climate strategy with the Paris Agreement. The asset manager criticized ...